Private Equity Firms in San Diego

Hayfin Capital Management LLP, founded in 2009, is a premier European alternative asset management platform specializing in providing critical debt, equity, and hybrid capital solutions tailored to meet diverse financing needs for corporates—including both sponsor-backed and non-sponsor entities—as well as real asset owners. The firm employs a value-investing approach across multiple strategies including Direct Lending, Special Opportunities, High-Yield Credit, Securitized Credit, and Private Equity Funds.Headquartered in London, Hayfin has expanded its global footprint with 13 offices spanning Europe, the United States, and a growing presence in Asia. Since inception, Hayfin has invested over €50 billion of capital across more than 500 portfolio companies, managing approximately €35 billion in assets under management. The firm’s investment philosophy combines deep market expertise, disciplined risk management, and a commitment to responsible investing, as evidenced by its signatory status to the Principles of Responsible Investment (PRI).Hayfin’s management team, including co-founders Tim Flynn (CEO) and Mark Tognolini (COO), emphasizes long-term partnership with clients and investors, fostering a culture of collaboration and innovation.

JMI Equity is a growth equity firm that partners with leading software companies. Founded in 1992, JMI has invested in over 190 businesses, including more than 100 cloud investments, and has completed over 120 exits. The firm's portfolio companies collectively generate $10 billion in revenue and represent $80 billion in enterprise value, employing over 36,000 people. With offices in Baltimore, San Diego, and Washington, D.C., JMI Equity provides flexible capital, strategic guidance, and operational support to help companies scale and build lasting value. The firm typically invests between $25 million and $250 million in companies with proven business models, high recurring revenue, and long-term growth potential. JMI Equity focuses on sectors such as cloud computing, energy, utilities, real estate, education, finance, insurance, legal, government, digital health, and information technology, primarily targeting companies in North America and Europe.

KA Enterprises was a San Diego, California-based investment firm specializing in real estate development and management, as well as petroleum and energy distribution. The firm focused on acquiring, developing, operating, managing, and leasing a diverse portfolio of assets, including commercial real estate (retail, multi-family, office, and industrial properties), high-end residential estates, and gasoline stations. They also operated as a wholesale fuel supplier, distributing multiple fuel brands across California and Nevada.Founded in 1995 in La Jolla, California, by three equal partners, Kambiz Agahnia, Kayvon Agahnia, and Ken Assi, KA Enterprises grew from a single gas station acquisition into a substantial organization. The firm's strategy involved a private equity-style approach to investing in gasoline stations and real estate, emphasizing thorough due diligence, value maximization, and capitalizing on market opportunities. Their headquarters were located in the Sorrento Valley business community of San Diego.Notable projects in their portfolio included the Del Mar Zapo House, a magnificent estate with scenic ocean views; the Billboard Lofts San Diego, an award-winning apartment building in Little Italy; and the La Jolla Gateway Retail Center, recognized for its distinctive design. The firm also developed and managed various retail centers, residential communities, and gas stations across multiple states.The leadership team comprised Kambiz Agahnia as Chairman, Kayvon Agahnia as Chief Operating Officer and Chief Financial Officer, and Ken Assi as Chief Investment Officer. Their collective expertise spanned decades in real estate, finance, investment management, and operations, contributing to the firm's growth into a $100 million-plus organization with over 100 employees. In December 2025, KA Enterprises was acquired by Brainbees, expanding Brainbees' footprint in the real estate and energy sectors.

OurCrowd is a global venture investing platform that democratizes access to private market opportunities for accredited investors, family offices, and institutions worldwide. The firm operates as both a digital platform and a professional venture firm, enabling investors to participate in pre-vetted startups, targeted venture funds, and a range of alternative assets. OurCrowd distinguishes itself by co-investing its own capital in every opportunity presented on its platform, offering its global network the same terms as institutional co-investors.Founded in 2013 by serial entrepreneur and venture capitalist Jonathan Medved, OurCrowd emerged from a vision to open up the traditionally exclusive world of venture capital. Medved, a pioneer in Israel's venture capital industry, sought to combine rigorous venture discipline with the expansive reach of an international investor network. The company launched in Jerusalem and has since expanded its global footprint with offices across three continents, serving investors from over 90 countries.OurCrowd's diverse portfolio spans over 500 companies and 68 funds, with notable investments in leading technology and innovation firms. Key portfolio companies include SpaceX, Anthropic, Databricks, xAI, Scale AI, Lemonade, Beyond Meat, and Kodiak Robotics. The firm has achieved over 60 exits, including successful IPOs and acquisitions such as Beyond Meat, Lemonade, Innoviz, Hub Security, Jump (sold to Uber), Wave (sold to H&R Block), Kenna (sold to Cisco), RePlay (sold to Intel), Argus (sold to Continental), Magisto (sold to Vimeo), and CyberX (sold to Microsoft).The OurCrowd team comprises seasoned investment professionals who evaluate hundreds of opportunities annually, applying a disciplined approach to curate investments that meet high standards of innovation, scalability, and market potential. Beyond capital, OurCrowd actively supports its portfolio companies through mentorship, strategic introductions, partnership building, and facilitating follow-on funding. Key team members include Jonathan Medved (Founder & Chairman) and Cali Chill (Acting CEO & Chief Operating Officer), who bring extensive experience in venture capital, legal operations, and investment strategy.

Takeda Ventures, Inc. (TVI) is the corporate venture capital arm of Takeda Pharmaceutical Company Limited, a global, patient-focused, R&D-driven biopharmaceutical company. Established in 2001, the firm's primary mission is to generate strategic growth opportunities for Takeda by investing in and nurturing innovative life science companies. Takeda Ventures focuses on high-caliber, therapeutic, and platform-based companies worldwide, specifically targeting early-stage and preclinical opportunities that complement Takeda's existing pipeline and R&D pillars.The firm was founded with the vision of generating disruptive technologies and therapeutic solutions for patients through venture-based investments. Takeda Ventures partners with academic innovators, entrepreneurs, and venture investors to build and manage a portfolio of companies aligned with Takeda's core R&D areas. These areas include Oncology, Rare Genetics & Hematology, Neuroscience, and Gastrointestinal and Inflammation. By providing access to the resources of a multinational pharmaceutical company, Takeda Ventures aims to support and accelerate therapeutic innovation.Takeda Ventures has made numerous investments in companies across its focus areas. Notable portfolio companies include Oryon Cell Therapies, Accipiter Biosciences, Integra Therapeutics, Nabla Bio, Ensoma, Cerevance, Oshi Health, and Obsidian Therapeutics. The firm's investment strategy also extends to digital health, artificial intelligence, blockchain, and Web3 technologies, reflecting a broader interest in innovations that can improve patient outcomes and healthcare delivery.The team at Takeda Ventures comprises experienced professionals dedicated to identifying and supporting promising startups. Key team members include Yoko Sugimoto, Mary Wirth, Hanna Vasiliuk, Michael Martin, Miles Gerson, and Victor Stone. Their collective expertise in private equity, technology, and healthcare, combined with a data-driven investment approach, enables the firm to execute deals and foster value creation at various investment stages, primarily targeting North America, Europe, and Asia Pacific.